Simvastatin "Aurobindo" 20 mg filmovertrukne tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

simvastatin "aurobindo" 20 mg filmovertrukne tabletter

aurobindo pharma limited - simvastatin - filmovertrukne tabletter - 20 mg

Simvastatin "Aurobindo" 40 mg filmovertrukne tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

simvastatin "aurobindo" 40 mg filmovertrukne tabletter

aurobindo pharma limited - simvastatin - filmovertrukne tabletter - 40 mg

Cipralex Meltz 10 mg smeltetabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

cipralex meltz 10 mg smeltetabletter

h. lundbeck a/s - escitalopram - smeltetabletter - 10 mg

Cipralex Meltz 20 mg smeltetabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

cipralex meltz 20 mg smeltetabletter

h. lundbeck a/s - escitalopram - smeltetabletter - 20 mg

Mifepriston "Linepharma" 200 mg tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

mifepriston "linepharma" 200 mg tabletter

linepharma international limited - mifepriston - tabletter - 200 mg

Duofaxin 150 mg depottabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

duofaxin 150 mg depottabletter

laboratorios liconsa s.a. - venlafaxinhydrochlorid - depottabletter - 150 mg

Duofaxin 225 mg depottabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

duofaxin 225 mg depottabletter

laboratorios liconsa s.a. - venlafaxinhydrochlorid - depottabletter - 225 mg

Duofaxin 75 mg depottabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

duofaxin 75 mg depottabletter

laboratorios liconsa s.a. - venlafaxinhydrochlorid - depottabletter - 75 mg

Sovaldi Euroopa Liit - taani - EMA (European Medicines Agency)

sovaldi

gilead sciences ireland uc - sofosbuvir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. for at hepatitis c virus (hcv) genotype specifik aktivitet, se afsnit 4. 4 og 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 og 5. for at hepatitis c virus (hcv) genotype specifik aktivitet, se afsnit 4. 4 og 5.

Alvesco 160 mikrogram/dosis inhalationsspray, opløsning Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

alvesco 160 mikrogram/dosis inhalationsspray, opløsning

covis pharma europe b.v. - ciclesonid - inhalationsspray, opløsning - 160 mikrogram/dosis